ACT and CIRM Together on Eye Research Webinar
Executives of Advanced Cell Technology, which has been repeatedly rejected for funding by the $3 billion California stem cell agency, will participate this week in the agency's Internet "webinar" on research involving the human eye.
ACT, which is engaged in the only hESC clinical trial in the nation, was held up earlier this month (see here and here) at…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.